Comparative study of intrathecal bupivacaine in combination with nalbuphine and bupivacaine for subarachnoid block in a tertiary care hospital

Introduction: Various adjuvant therapies have been developed to prolong intra and postoperative analgesia. A comparative study was conducted to evaluate the onset, maximum level, and duration of motor and sensory block, as well as the duration of analgesia, side effects like hypotension, bradycardia...

Full description

Saved in:
Bibliographic Details
Main Authors: Lavanya Bachula, Nallolla Rahul Dev, P.V. Shiva, Sunil Kumar Cherukuri
Format: Article
Language:English
Published: Tabriz University of Medical Sciences Press 2024-12-01
Series:Journal of Research in Clinical Medicine
Subjects:
Online Access:https://jrcm.tbzmed.ac.ir/PDF/jrcm-12-38.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850075373455278080
author Lavanya Bachula
Nallolla Rahul Dev
P.V. Shiva
Sunil Kumar Cherukuri
author_facet Lavanya Bachula
Nallolla Rahul Dev
P.V. Shiva
Sunil Kumar Cherukuri
author_sort Lavanya Bachula
collection DOAJ
description Introduction: Various adjuvant therapies have been developed to prolong intra and postoperative analgesia. A comparative study was conducted to evaluate the onset, maximum level, and duration of motor and sensory block, as well as the duration of analgesia, side effects like hypotension, bradycardia, sedation, and respiratory depression in patients undergoing elective lower segment caesarean section (LSCS). Methods: The study included 60 patients, divided in to two groups to receive intrathecal hyperbaric bupivacaine (0.5%) in combination with nalbuphine (0.8 mg) (group A) and intrathecal hyperbaric bupivacaine alone (group B). Demographic data, onset of sensory and motor block, regression of motor block, duration of analgesia, hemodynamic changes, and side effects during the procedure were recorded. Results: A statistically significant difference was observed in time of onset of sensory and motor block, and maximum percentage of sensory block was attained in group B (bupivacaine) with 90% of patients. Mean duration of sensory regression to S1 was attained at 120.16 minutes in group A (bupivacaine+nalbuphine). Mean duration of analgesia was attained at 203.33 minutes in group A, and haemodynamic parameters have remained below the baseline value in both the groups. Side effects during the surgery were statistically insignificant. Conclusion: Intrathecal nalbuphine (0.8 mg) is an effective adjuvant to 0.5% hyperbaric bupivacaine in subarachnoid block for patients undergoing elective LSCS. It provides prolonged postoperative analgesia without much side effects and may be used as a better alternative over other opioids.
format Article
id doaj-art-40d9eadef16d4a63ac8d029d3c06558d
institution DOAJ
issn 2717-0616
language English
publishDate 2024-12-01
publisher Tabriz University of Medical Sciences Press
record_format Article
series Journal of Research in Clinical Medicine
spelling doaj-art-40d9eadef16d4a63ac8d029d3c06558d2025-08-20T02:46:20ZengTabriz University of Medical Sciences PressJournal of Research in Clinical Medicine2717-06162024-12-01121383810.34172/jrcm.34742jrcm-34742Comparative study of intrathecal bupivacaine in combination with nalbuphine and bupivacaine for subarachnoid block in a tertiary care hospitalLavanya Bachula0Nallolla Rahul Dev1P.V. Shiva2Sunil Kumar Cherukuri3Government Medical College, Sangareddy, IndiaDepartment of Anesthesiology, Yashoda Hospital, Malakpet, Hyderabad, IndiaDepartment of Anesthesiology, Niloufer Hospital, Red Hills, Osmania Medical College, Koti, Hyderabad, IndiaGovernment Medical College, Jagtial, IndiaIntroduction: Various adjuvant therapies have been developed to prolong intra and postoperative analgesia. A comparative study was conducted to evaluate the onset, maximum level, and duration of motor and sensory block, as well as the duration of analgesia, side effects like hypotension, bradycardia, sedation, and respiratory depression in patients undergoing elective lower segment caesarean section (LSCS). Methods: The study included 60 patients, divided in to two groups to receive intrathecal hyperbaric bupivacaine (0.5%) in combination with nalbuphine (0.8 mg) (group A) and intrathecal hyperbaric bupivacaine alone (group B). Demographic data, onset of sensory and motor block, regression of motor block, duration of analgesia, hemodynamic changes, and side effects during the procedure were recorded. Results: A statistically significant difference was observed in time of onset of sensory and motor block, and maximum percentage of sensory block was attained in group B (bupivacaine) with 90% of patients. Mean duration of sensory regression to S1 was attained at 120.16 minutes in group A (bupivacaine+nalbuphine). Mean duration of analgesia was attained at 203.33 minutes in group A, and haemodynamic parameters have remained below the baseline value in both the groups. Side effects during the surgery were statistically insignificant. Conclusion: Intrathecal nalbuphine (0.8 mg) is an effective adjuvant to 0.5% hyperbaric bupivacaine in subarachnoid block for patients undergoing elective LSCS. It provides prolonged postoperative analgesia without much side effects and may be used as a better alternative over other opioids.https://jrcm.tbzmed.ac.ir/PDF/jrcm-12-38.pdfbupivacainecaesarean sectionintrathecalnalbuphine
spellingShingle Lavanya Bachula
Nallolla Rahul Dev
P.V. Shiva
Sunil Kumar Cherukuri
Comparative study of intrathecal bupivacaine in combination with nalbuphine and bupivacaine for subarachnoid block in a tertiary care hospital
Journal of Research in Clinical Medicine
bupivacaine
caesarean section
intrathecal
nalbuphine
title Comparative study of intrathecal bupivacaine in combination with nalbuphine and bupivacaine for subarachnoid block in a tertiary care hospital
title_full Comparative study of intrathecal bupivacaine in combination with nalbuphine and bupivacaine for subarachnoid block in a tertiary care hospital
title_fullStr Comparative study of intrathecal bupivacaine in combination with nalbuphine and bupivacaine for subarachnoid block in a tertiary care hospital
title_full_unstemmed Comparative study of intrathecal bupivacaine in combination with nalbuphine and bupivacaine for subarachnoid block in a tertiary care hospital
title_short Comparative study of intrathecal bupivacaine in combination with nalbuphine and bupivacaine for subarachnoid block in a tertiary care hospital
title_sort comparative study of intrathecal bupivacaine in combination with nalbuphine and bupivacaine for subarachnoid block in a tertiary care hospital
topic bupivacaine
caesarean section
intrathecal
nalbuphine
url https://jrcm.tbzmed.ac.ir/PDF/jrcm-12-38.pdf
work_keys_str_mv AT lavanyabachula comparativestudyofintrathecalbupivacaineincombinationwithnalbuphineandbupivacaineforsubarachnoidblockinatertiarycarehospital
AT nallollarahuldev comparativestudyofintrathecalbupivacaineincombinationwithnalbuphineandbupivacaineforsubarachnoidblockinatertiarycarehospital
AT pvshiva comparativestudyofintrathecalbupivacaineincombinationwithnalbuphineandbupivacaineforsubarachnoidblockinatertiarycarehospital
AT sunilkumarcherukuri comparativestudyofintrathecalbupivacaineincombinationwithnalbuphineandbupivacaineforsubarachnoidblockinatertiarycarehospital